FENNEC PHARMACEUTICALS INC.

FENC Nasdaq CIK: 0001211583

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation British Columbia, Canada
Business Address PO BOX 13628, RESEARCH TRIANGLE PARK, NC, 27709
Mailing Address PO BOX 13628, RESEARCH TRIANGLE PARK, NC, 27709
Phone (919) 636-4530
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
10-K Annual financial report March 27, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
4 Insider stock transaction report March 26, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC

Annual Reports

10-K March 27, 2026
  • Successful commercial launch of PEDMARK with $20.4 million in 2023 revenue.
  • Achieved significant regulatory milestones with FDA and European approvals.
View Analysis

Insider Trading

STRONG SELL 2 insiders 5 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.